# JOUNCE THERAPEUTICS INC (JNCE)

> Institutional ownership reported to the SEC as of Q2 2023, from Form 13F filings. Source: https://holderbook.com/stocks/JNCE/

- Reporting holders: 1
- Reported value: $917.8K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Opaleye Management Inc.](https://holderbook.com/funds/1595855-opaleye-management-inc/) | $917.8K | 669,944 | 0.2% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2023 | 1 | $917.8K |
| Q1 2023 | 85 | $64.3M |
| Q4 2022 | 84 | $39.8M |
| Q3 2022 | 101 | $100.1M |
| Q2 2022 | 100 | $129.4M |
| Q1 2022 | 112 | $287.9M |
| Q4 2021 | 125 | $349.6M |
| Q3 2021 | 115 | $271.4M |
| Q2 2021 | 129 | $247.3M |
| Q1 2021 | 119 | $382.1M |
| Q4 2020 | 103 | $197.3M |
| Q3 2020 | 101 | $210.7M |